It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy,...

THURSDAY, Oct. 31, 2024 -- Injected micronized amnion/chorion bilayer (AC) product significantly reduces time to symptom relief in patients with...

MONDAY, Oct. 28, 2024 -- Most thyroid cancers are slow-moving and, if caught early, curable. But some patients can present with what's known as an...

It is gen Z’s recreational drug of choice in the UK and US – and with rising use come big problems, including incontinence, bladder damage, renal...

Researchers from The University of Texas MD Anderson Cancer Centre, USA, demonstrated that anti-PD-L1 immunotherapy in combination with...

A new case report was published in Oncoscience (Volume 11) on October 8, 2024, entitled, “Complete and long-lasting response to immunotherapy in...

FRIDAY, Nov. 1, 2024 -- Lack of health insurance coverage accounts for a considerable proportion of racial and ethnic disparities in advanced-stage...

FRIDAY, Nov. 1, 2024 -- Lack of health insurance coverage accounts for a considerable proportion of racial and ethnic disparities in advanced-stage...